Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.69 USD | -3.43% | -5.56% | +200.88% |
09/05 | Earnings Flash (NKTR) NEKTAR THERAPEUTICS Reports Q1 Revenue $21.6M, vs. Street Est of $15.3M | MT |
09/05 | Transcript : Nektar Therapeutics, Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+200.88% | 32Cr | |
+38.03% | 72TCr | |
+34.22% | 59TCr | |
-2.78% | 37TCr | |
+20.51% | 33TCr | |
+2.60% | 28TCr | |
+17.04% | 24TCr | |
+9.51% | 21TCr | |
-4.70% | 21TCr | |
+0.47% | 17TCr |
- Stock Market
- Equities
- NKTR Stock
- News Nektar Therapeutics
- Nektar Therapeutics Promotes Jillian Thomsen to CFO